Ebola Vaccine Gets First Approval in Europe
European health authorities gave the world’s first Ebola vaccine a green light on Monday, marking a major breakthrough in the quest to prevent exposure to the deadly disease.
The European Commission adopted a recommendation to grant marketing authorization for the Ervebo vaccine, manufactured by Merck. The decision comes less than a month after European regulators recommended the drug’s approval.
Consider supporting our journalism with a contribution of any size. Readers from around the world, like you, make AMIBC™s work possible. We need your support to deliver quality, vetted, investigative journalism – and to keep it open for everyone. At a time when factual, honest reporting is critical, your support is essential in protecting our editorial independence.
The African-American narrative and issues impacting the culture is tantamount to the AMIBC™ platform. Every contribution, however big or small, is valuable for our future. Make sure to join the AMIBC Founders Club to maximize the total advantage of being a subscriber. Contribute by clicking on the advertisers featured on this site and utilize them.
